Medical Device Network

On 2 April 2025, engineers at Northwestern University published a study on a new dissolvable pacemaker, smaller than a grain of rice and powered by light. This device, which can be implanted nonsurgically using a syringe, has the potential to save the lives of newborns with heart problems and may also assist adults with certain heart defects. Click here for the full article - https://lnkd.in/dJBsqhzT #pacemaker #cardiology #medicaldevice #medtech #medicaltechnology

Virtual reality (VR) technology is transforming the medical field, according to a new report. Specifically, GlobalData Healthcare’s Virtual Reality in Medical report details that technology is bringing advancements that enhance training, prototyping and patient treatment. It explains: “By offering immersive, interactive and precise simulations, VR has become a valuable tool in medical and surgical training, medical device prototyping and testing and patient treatment and diagnostics.” Click here for the full article - https://lnkd.in/ddgPdkMP Click here if you would like to purchase the report - https://lnkd.in/dA3FbtkC #medicaldevice #medtech #virtualreality #medicaltechnology #medicaltraining #medicaldiagnostics #patientcare

South Korean startups showcased innovative technologies addressing dementia care and prevention for aging national populations. Click here for the full article - https://lnkd.in/gf9bzUbz #medicaldevice #medtech #dementia #UKhealthcare

Whether or not an ally of the US, President Trump has moved to impose tariffs on multiple countries, including all trade partners, in an action expected to stoke a global trade war. The Advanced Medical Technology Association (AdvaMed) highlighted that it supports “any and every” policy that allows the US to maintain its position of global primacy in “every aspect of medical innovation imaginable”, adding that it “fully supports” the President’s goal of moving as much manufacturing into the US as possible. However, we are disappointed in the news of the administration’s intent to levy broad tariffs that will negatively impact American medical technology and innovation,” AdvaMed president and CEO Scott Whitaker said in a statement. Click here for the for article - https://lnkd.in/dAnZVT5W #medicaldevice #tariffs #medtech

Siemens Healthineers and Tower Health have entered a “Value Partnership”, aiming to enhance technology, equipment and patient clinical experiences. Tower Health CEO and president Michael Stern said: “This partnership extends beyond merely upgrading equipment; it empowers Tower Health and our staff to uphold our dedication to clinical excellence and innovation, ensuring the delivery of smarter, faster, and more connected care to our patients and the communities we serve for years to come. We are proud to establish a strategic partnership with Siemens Healthineers, granting us access to state-of-the-art technology during the next decade. Such strategic partnerships are crucial for securing our enduring success, our dedication to pioneering advancements, and our exceptional clinical standards.” Click here for the full article - https://lnkd.in/dfb4WuFS #medicaldevice #medtech #medicaltechnology

CMR Surgical has completed a financing round of more than $200m, combining equity and debt capital to expedite the commercialisation of its Versius Surgical Robotic System, particularly focusing on the US market. CMR Surgical CEO Massimiliano Colella said: “We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion, including in the US, while continuing to penetrate deeper into existing markets. I would like to give thanks to our chief financial officer, Andre Nel, and the team for securing this financing to provide the foundation for realising our strategic vision of making robotic-assisted surgery accessible to all patients who need it whilst accelerating future product development.” Click here for the full article - https://lnkd.in/dPhz7v2v #medicaldevice #medtech #robotics #medicalrobotics #surgicalrobotics

Per a communiqué issued by the White House last week, layoffs at HHS departments including the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) would total around 10,000. Including voluntary resignations and retirements, the plans to drive governmental efficiency and ‘Make America Healthy Again’ were projected to reduce the total full-time employees under the combined HHS agencies from 82,000 to 62,000. Medical device contract research organisation (CRO) NAMSA hosted a webinar on 3 April to discuss the potential impact of the layoffs on the medical device industry. Addressing the potential impact of the cuts to the FDA’s review and approval process of medical devices, Dr Jeff Shuren, who served as director of the FDA’s Center for Devices and Radiological Health (CDRH) from 2009 until July 2024, said it would “not be surprising” if the cuts resulted in longer device review times, at least in the near term. “One of the challenges moving forward will be to assure that the FDA’s premarket review programme has the expertise that it needs, and that time and attention is put into recruitment and retention.” https://lnkd.in/eBzVYiGk

Under plans outlined by HHS Secretary Robert F Kennedy, Jr (RFK Jr), thousands of employees at the health agencies under the HHS received notices on 1 April that their jobs were being eliminated. Last week, under a transformation plan touted to ‘Make America Healthy Again’, the White House revealed plans to cut around 10,000 employees from HHS departments, including the US Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). The Trump administration estimated that the cuts, including retirements and voluntary resignations, would result in a culling of the combined agencies’ workforce from 82,000 full-time employees to 62,000. AFGE national president Everett Kelley lambasted the HHS agency cuts, branding them “dangerous, irresponsible, and unacceptable”. In a similar vein, the Infectious Diseases Society of America maligned the job cuts, stating that “we cannot do the complex and serious work of protecting Americans from infectious diseases amid this chaos and confusion” and concluding that the actions were “counter” to the goal of keeping America healthy. https://lnkd.in/evwWhXnr

Swiss-based SHL Medical has opened a new autoinjector manufacturing facility in North Charleston, South Carolina, US, with a $220m investment. SHL Medical chairman and CEO Ulrich Fässler said: “US-based production is a major step forward in our global expansion and reinforces our position as the leader in providing end-to-end drug delivery solutions. With our established site in Taiwan and the upcoming facility in Switzerland, we will be the only autoinjector manufacturer operating across three continents, bringing us even closer to our customers.” Click here for the full article - https://lnkd.in/d3B9qaJs #medicaldevice #medtech #drugdelivery #autoinjector #medicaldevicemanufacturing